Breast cancer risk associated with benign breast disease: systematic review and meta-analysis Sara W. DyrstadYan YanGraham A. Colditz Review 31 January 2015 Pages: 569 - 575
Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia Marie-José BlouinMiguel BazileMichael Pollak Preclinical study 23 January 2015 Pages: 577 - 585
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis C. C. EngelsA. CharehbiliP. J. K. Kuppen Preclinical study Open access 24 January 2015 Pages: 587 - 596
Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells Kyoko ShimoyamaShunsuke KagawaToshiyoshi Fujiwara Preclinical study 24 January 2015 Pages: 597 - 605
The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells Jillian E. KozielBrittney-Shea Herbert Preclinical study 28 January 2015 Pages: 607 - 618
Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis Jian WenSyn YeoJun-Lin Guan Preclinical study 01 February 2015 Pages: 619 - 629
Bcl2 and Ki67 refine prognostication in luminal breast cancers Lin-Ying ChenJulia Y. S. TsangGary M. Tse Preclinical study 04 February 2015 Pages: 631 - 643
First trimester human placental factors induce breast cancer cell autophagy G. Epstein ShochetL. DruckerM. Lishner Preclinical Study 06 February 2015 Pages: 645 - 654
Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2′-deoxycytidine in human breast cancer cells Tulika TyagiJustin N. TreasKamaleshwar P. Singh Preclinical study 08 February 2015 Pages: 655 - 668
In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response Sara A. HurvitzOndrej KalousDennis J. Slamon Preclinical study 08 February 2015 Pages: 669 - 680
The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate Su-Hyeong KimShivendra V. Singh Preclinical Study 08 February 2015 Pages: 681 - 692
DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells Marleen AnsemsJonas Nørskov SøndergaardGosse J. Adema Preclinical Study Open access 08 February 2015 Pages: 693 - 703
Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways Hongkai WangWeiwei ShenTongwei Chu Preclinical study 10 February 2015 Pages: 705 - 714
Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells Stine HoleAstrid M. PedersenChristina W. Yde Preclinical Study 10 February 2015 Pages: 715 - 726
Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer Sung Yeon ParkHye Min KimJa Seung Koo Preclinical study 10 February 2015 Pages: 727 - 741
The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most? Eunpi ChoLena RubinsteinVijayakrishna K. Gadi Clinical Trial 01 February 2015 Pages: 743 - 749
Effect of menstrual cycle and menopausal status on apparent diffusion coefficient values and detectability of invasive ductal carcinoma on diffusion-weighted MRI Suyoung ShinEun Sook KoSoo Yeon Hahn Clinical trial 01 February 2015 Pages: 751 - 759
Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer Yu FengRui HuangTao Ouyang Clinical Trial 10 February 2015 Pages: 761 - 765
Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients Zibo LiXinwu GuoJun Wang Epidemiology 31 January 2015 Pages: 767 - 779
Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study Alexandra GomezAlberto J. MonteroJudith Hurley Epidemiology 07 February 2015 Pages: 781 - 788
Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers Sabrina S. KhanThomas KarnChristos Hatzis Brief Report 05 February 2015 Pages: 789 - 797
Meta-analyses of etiologic studies should account for the underlying biologic mechanisms Heather K. Neilson Letter to the Editor 06 February 2015 Pages: 799 - 800
Meta-analyses of etiologic studies should account for the underlying biologic mechanisms Yili WuDongfeng Zhang Rebuttal letter 03 February 2015 Pages: 801 - 803
